Roche Holding AG (ETR:RHO)

Market Cap	267.78B
Revenue (ttm)	67.98B
Net Income (ttm)	10.10B
Shares Out	n/a
EPS (ttm)	12.57
PE Ratio	26.52
Forward PE	15.36
Dividend	9.70 (2.95%)
Ex-Dividend Date	Mar 27, 2025

Volume	52
Average Volume	306
Open	331.60
Previous Close	330.20
Day's Range	328.00 - 331.80
52-Week Range	272.60 - 331.80
Beta	n/a
RSI	70.39
Earnings Date	Oct 20, 2025

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagn...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1896
• Employees: 103,249
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: RHO

Financial Performance

In 2024, Roche Holding AG's revenue was 62.40 billion, an increase of 3.23% compared to the previous year's 60.44 billion. Earnings were 8.28 billion, a decrease of -28.01%.

Financial numbers in CHF